You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IFOSFAMIDE

Showing 1 - 25 of 558
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Trial in Guangzhou (Sintilimab plus chemo)

Recruiting
  • Soft Tissue Sarcoma
  • Sintilimab plus chemotherapy
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue Trial in Saint Louis (ADI PEG20, Ifosfamide, Radiotherapy)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • ADI PEG20
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 2, 2023

Penile Cancer Trial in Guangzhou (Albumin-Bound Paclitaxel, Ifosfamide, Cisplatin)

Completed
  • Penile Cancer
  • Albumin-Bound Paclitaxel
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 8, 2022

Pediatric Germ Cell Tumor Trial in Seoul (TIP treatment (paclitaxel/ifosfamide/cisplatin))

Recruiting
  • Pediatric Germ Cell Tumor
  • TIP treatment (paclitaxel/ifosfamide/cisplatin)
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jul 8, 2022

Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
Mar 12, 2022

Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma Trial in Santa Monica (aldoxorubicin, ifosfamide)

Completed
  • Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

Recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Pembroke Pines, Florida
  • +3 more
Jan 23, 2023

Soft Tissue Sarcoma Trial in Guangzhou (Apatinib Mesylate, doxorubicin, ifosfamide)

Recruiting
  • Soft Tissue Sarcoma
  • Apatinib Mesylate, doxorubicin, ifosfamide
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Nov 15, 2021

Classic Hodgkin's Lymphoma Trial in Beijing (Sintilimab, Carboplatin, Etoposide)

Recruiting
  • Classic Hodgkin's Lymphoma
  • Sintilimab
  • +4 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Sep 12, 2022

Effect of Drug, Drug, Toxicity Trial in Beijing (Apatinib+IE, IE)

Recruiting
  • Effect of Drug
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Mar 12, 2022

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Soft Tissue Sarcoma Trial in Bergen, Oslo (Ifosfamide, Doxorubicin)

Recruiting
  • Soft Tissue Sarcoma
  • Bergen, Norway
  • +1 more
Sep 10, 2021

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Aggressive Non-Hodgkin Lymphoma Trial in Belgium, France (drug, other, procedure)

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • Brugge, Belgium
  • +21 more
Jan 9, 2023

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Duarte, California
  • +3 more
Oct 24, 2022

Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

Active, not recruiting
  • Testicular Cancer
  • Houston, Texas
  • +1 more
Dec 5, 2022

Hodgkin Lymphoma Trial in Saint Petersburg, Irkutsk (Nivolumab, Ifosfamide, Carboplatin)

Recruiting
  • Hodgkin Lymphoma
  • Saint Petersburg, Pesochny, Russian Federation
  • +2 more
Jul 19, 2021

Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

Not yet recruiting
  • Mature B-Cell Non-Hodgkin Lymphoma
  • (no location specified)
Sep 6, 2022

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021

Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)

Recruiting
  • Lymphoma
  • Radiation Therapy
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Non-metastatic Soft-tissue Sarcoma, Resectable Trial in France (Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the

Recruiting
  • Non-metastatic Soft-tissue Sarcoma
  • Resectable
  • Bordeaux, France
  • +9 more
Jul 27, 2022

Sarcoma, Soft Tissue Trial in Worldwide (Nintedanib, Ifosfamide)

Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
Sep 10, 2021

Effect of Drug, Toxicity, Drug Trial in Beijing (apatinib)

Recruiting
  • Effect of Drug
  • Toxicity, Drug
  • Beijing, Beijing, China
  • +1 more
Jul 12, 2021

Soft Tissue Sarcoma Trial in Bordeaux, Montpellier, Toulouse (Patients starting a treatment with Doxorubicin and Ifosfamide)

Completed
  • Soft Tissue Sarcoma
  • Patients starting a treatment with Doxorubicin and Ifosfamide
  • Bordeaux, France
  • +2 more
Jan 11, 2021

NSCLC Trial in Seoul (Durvalumab + doxorubicin + ifosfamide)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Durvalumab + doxorubicin + ifosfamide
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 30, 2020